Assignee
AMYLIN PHARMACEUTICALS LLC
US·9 granted patents·31 pending applications·40 citations·filing 2012–2020
Top patents by PatentIndex Score
40 records- 0192US8906851B2Method for treating diabetesAMYLIN PHARMACEUTICALS LLC·Filed 2012·Granted Dec 9, 2014·17 cites·8 claims
- 0288US8603761B2GLP-1 receptor agonist bioassayAMYLIN PHARMACEUTICALS LLC·Filed 2012·Granted Dec 10, 2013·14 cites·20 claims
- 0378US9593154B2Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Mar 14, 2017·4 cites·10 claims
- 0477US8951962B2Modified exendins and exendin agonistsAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Feb 10, 2015·4 cites·12 claims
- 0570US9133260B2GIP analog and hybrid polypeptides with selectable propertiesAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Sep 15, 2015·1 cites·8 claims
- 0670US2020222509A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 0768US2015111824A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 0866US9453063B2Hybrid polypeptides with selectable propertiesAMYLIN PHARMACEUTICALS LLC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 0966US2015080307A1Exendins and exendin agonist analogs to regulate gastrointestinal motilityAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1066US2013209586A1Prevention And Treatment Of Cardiac ArrhythmiasAMYLIN PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 1165US9034819B2Method of lowering cholesterol and triglycerides by administering exendinsAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted May 19, 2015·0 cites·6 claims
- 1265US2015150948A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1364US2015080308A1Formulations and Uses of Exendins and Exendin Agonist AnalogsAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1464US2018333468A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 1563US2015157725A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1663US2013023470A1Exendin and exendin agonists for eating disordersAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 1762US9884092B2Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2016·Granted Feb 6, 2018·0 cites·22 claims
- 1862US2015231204A1Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1962US2020405815A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2061US2013203661A1Highly soluble leptinsAMYLIN PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 2160US8906849B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Dec 9, 2014·0 cites·8 claims
- 2259US2013225485A1Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating DisordersAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 2359US2013165379A1Formulations of Exendins and Exendin Agonist AnalogsAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 2457US2015056285A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2557US2014371148A1Peptide-peptidase inhibitor conjugates and methods of using sameAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2655US2018271946A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 2755US2014206613A1Methods to restore glycemic controlAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2855US2015238568A1Exendins to lower cholesterol and triglyceridesAMYLIN PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2951US2016346357A1Sustained release formulations using non-aqueous carriersAMYLIN PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 3050US2013023466A1Peptide YY and Peptide YY Agonists for Treatment of Metabolic DisordersAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3150US2016361390A1Glp-1 receptor agonist compounds for obstructive sleep apneaAMYLIN PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 3248US2016120950A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3348US2013023471A1Methods to restore glycemic controlAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3447US2015258177A1Glp-1 receptor agonist compounds for obstructive sleep apneaAMYLIN PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3545US2013035294A1Neuromedin and FN-38 Peptides for Psychotic DiseasesAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3644US2015111246A1Site-specific enzymatic modification of exendins and analogs thereofAMYLIN PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 3743US2017114114A1Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 3843US2014249076A1Amylin-calcitonin chimeric peptides conjugated to duration enhancing moietiesAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3939US2015133373A1Transmucosal delivery of engineered polypeptidesAMYLIN PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 4034US2015174209A1Insulin-pramlintide compositions and methods for making and using themAMYLIN PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AMYLIN PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →